Paxlovid, an antiviral used to treat Covid-19, was authorized for emergency use in the United States in mid-December 2021. More than 800,000 courses have been administered so far, but there's very little information about who is getting those prescriptions.
Mandatory Credit: C.Lujan/Europe Press/Getty Images
Stories this photo appears in:
Paxlovid is widely available, but details on who's getting it are sparse
Paxlovid, an antiviral treatment for Covid-19, was hailed as a game-changer in the pandemic thanks to its strong performance in lowering the risk of severe disease. Early supply challenges have been overcome in the United States, and the drug is perhaps more important than ever as case counts rise and more contagious variants spread amid stalled vaccination rates.
